METROHEALTH MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $11.9M
- Transactions
- 1,210
- Companies
- 40
- Average per transaction
- $9,809
Who reported the payments
| Amgen | $3,232,487 |
| Gilead | $1,580,638 |
| AbbVie | $969,769 |
| E.r. Squibb & Sons, L.L.C. | $846,752 |
| Coloplast | $658,261 |
| CSL Behring | $558,583 |
| Merck | $532,882 |
| Pfizer | $333,275 |
| Synthes GmbH | $312,346 |
| Beckman Coulter, Inc. | $270,523 |
| Siemens Medical Solutions USA, Inc. | $212,357 |
| Medical Device Business Services, Inc. | $204,018 |
| Stryker | $188,441 |
| Biosense Webster, Inc. | $187,626 |
| AstraZeneca | $168,956 |
| Takeda Pharmaceuticals U.S.A., Inc. | $160,360 |
| Bristol Myers Squibb | $154,884 |
| American Regent | $130,510 |
| Livanova USA, Inc. | $117,397 |
| Intercept Pharmaceuticals, Inc. | $104,138 |
| Bayer | $97,010 |
| Tanabe Pharma America, Inc. | $82,687 |
| SPR Therapeutics, Inc | $80,177 |
| Novartis | $70,378 |
| Inspire Medical Systems, Inc. | $62,918 |
| Astrazeneca UK Limited | $57,232 |
| UCB SA | $50,802 |
| Avadel CNS Pharmaceuticals, LLC | $48,473 |
| UCB GmbH | $28,146 |
| Abbott | $26,924 |
| Esperion Therapeutics, Inc. | $19,550 |
| Johnson & Johnson | $19,515 |
| Linde Gas & Equipment Inc. | $19,474 |
| Aurinia Pharma U.S., Inc. | $18,500 |
| Alydia Health | $17,110 |
| Eli Lilly | $15,145 |
| Medtronic | $15,000 |
| Intercept Pharma Europe Ltd. | $14,133 |
| Karyopharm Therapeutics Inc. | $12,750 |
| Axonics, Inc. | $11,448 |